longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

520880

----
Start trading
OverviewOverviewNewsNewsPostsPostsWikiWikiRatingsRatingsCompositionCompositionDividendsDividends
LongbridgeAI
  • Weekly Recap | INNOVENT BIO -7.65%, most brokers rate it buy

    Weekly Review·Sep 12 at 05:24 AM
    01801-1.91%
  • Weekly Recap | ZAI LAB -5.68%, consensus target above spot

    Weekly Review·Sep 12 at 07:37 AM
    09688+0.42%
  • Weekly Recap | 3SBIO -3.74%

    Weekly Review·Sep 12 at 05:17 AM
    01530-1.17%
  • Weekly Recap | BEONE MEDICINES -4.18%, consensus target above spot

    Weekly Review·Sep 12 at 07:17 AM
    06160-0.19%
  • Weekly Recap | SKB BIO -5.14%, most brokers rate it buy

    Weekly Review·Sep 12 at 07:22 AM
    06990-3.91%
  • Weekly Recap | CSPC PHARMA -10.02%, several pipeline programmes cleared

    Weekly Review·Sep 12 at 05:12 AM
    01093-1.86%
  • Weekly Recap | KEYMED BIO-B -6.47%, a pull-back after an early rally

    Weekly Review·Sep 12 at 05:29 AM
    02162-0.47%
  • Weekly Recap | SBP GROUP -4.02%, most brokers rate it buy

    Weekly Review·Sep 12 at 05:13 AM
    01177-1.00%
  • Weekly Recap | AKESO -5.94%, most brokers rate it buy

    Weekly Review·Sep 12 at 07:37 AM
    09926-0.47%
  • Weekly Recap | CSPC PHARMA +4.82%, three pipeline updates in one week

    Weekly Review·Sep 5 at 07:56 AM
    01093-1.86%
  • Weekly Recap | BEONE MEDICINES +2.51%, in US pricing deal

    Weekly Review·Sep 5 at 05:36 AM
    06160-0.19%
  • Weekly Recap | ZAI LAB this week, most brokers rate it buy

    Weekly Review·Sep 5 at 05:53 AM
    09688+0.42%
  • Weekly Recap | 1177.HK +1.56%, most brokers rate it buy

    Weekly Review·Sep 5 at 04:41 AM
    01177-1.00%
  • Weekly Recap | 3SBIO +0.74%, consensus target above spot

    Weekly Review·Sep 5 at 04:46 AM
    01530-1.17%
  • Weekly Recap | AKESO +12.57%, ivonescimab hits survival endpoint

    Weekly Review·Sep 5 at 05:56 AM
    09926-0.47%